Neuroscience
Driven with purpose to conduct clinical research impacting human health and public policy, our clinical neuroscience team has contributed to the testing of innovative therapeutic solutions for decades. BioFicher collaborates with a diverse client base of public and private sector organizations to enhance clinical practice and treatments for patients with neurological and psychiatric disorders. Our broad experience includes expertise in epilepsy, traumatic brain injury, autism, stroke, Alzheimer’s disease, schizophrenia, major depression and substance use.
With specific global experience in age-related Major Depressive Disorder, Epilepsy, Dementia and Schizophrenia, and several rare diseases, our team of experienced clinical research professionals is here to support your research and help improve the treatment landscape for Neuroscience patients.
.jpg)
To help advance your neuroscience research program, BioFicher offers Phase I-IV clinical trial research services, from protocol development to regulatory submissions and publications. Our global monitoring capability across North America, Europe, and Asia ensures you can recruit the sites and patients necessary to complete your studies. To gain the insights required from your clinical trial, our team of experienced biostatisticians and clinicians employ validated neuropsychological and quality of life (QOL) assessments in your study design.
Experimental neurology clinical trial protocols often require complex testing involving a variety of technologies. BioFicher can help you optimize the collection, processing, and analysis of data collected from sites and patients across a variety of neurological diagnostic tools (e.g.,CT, structural MRI, fMRI, MR spectroscopy, EEG, diffusion tensor imaging) using our Advantage eClinical suite of clinical technologies.
To achieve your objectives of maximizing site and patient-level data, we provide electronic data capture of CRFs, patient reported outcomes and diaries, as well as data from phone apps, wearables, and other digital technologies.
Neuroscience Clinical Experience
Many of those breakthroughs result from advances in cell and gene therapy, a key area of specialization for BioFicher. Through our core competency in cell and gene therapy, BioFicher provides you with unique perspectives and expert insights into the latest research in AMD. From our work on the AREDS and AREDS 2 trials, to the gene therapy and stem cell studies we conduct today,BioFicher has supported clients at the forefront of AMD science. As a result of our collaborations, AREDS products are available to patients at risk for Advanced AMD.
Our role in the consortium is to make tissue samples and data easily collectible, traceable, and accessible to researchers through the NNTC website (managed by BioFicher). We also conduct a battery of ante and post-mortem tests on HIV/AIDS patients as well as provide data warehousing services for the program. To date, the NNTC effort has generated over 500 publications that advance the understanding of neurological and psychological disorders of HIV/AIDS patients.
Our role in the consortium is to make tissue samples and data easily collectible, traceable, and accessible to researchers through the NNTC website (managed by BioFicher). We also conduct a battery of ante and post-mortem tests on HIV/AIDS patients as well as provide data warehousing services for the program. To date, the NNTC effort has generated over 500 publications that advance the understanding of neurological and psychological disorders of HIV/AIDS patients.
Specialty Neuroscience Products and Services
At BioFicher, we value the open exchange of communication between our therapeutic area leaders and your team. We encourage you to contact us to discuss your research plan and determine how we can support your development pathway.
Our history and proven outcomes working with multiple ophthalmic disease states, patient populations and recruitment strategies provide an optimal package for supporting your ophthalmology clinical research.
Patient
We are dedicated to improving the lives of patients fighting Stroke and Multi Sclerosis disease and critical illness.
MORE ABOUT US
Neuroscience Leaders
At BioFicher, we value the open exchange of communication between our therapeutic area leaders and your team. We encourage you to contact us to discuss your research plan and determine how we can support your development pathway.
Taylor James, MD, Ph.D.
TRU Director-Biostatistician